Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Plus Therapeutics Inc. (PSTV)

November 26, 2024 7:07 AM EST Send to a Friend
H.C. Wainwright analyst Sean Lee reiterated a Buy rating and $8.00 price target on Plus Therapeutics Inc. (NASDAQ: PSTV).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login